| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |